Search

everythinglearnresearchcommunity

for

Search:↓

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Dermatologists vary widely in testing practices for alopecia areata, often exceeding guideline recommendations.

A high dietary antioxidant index may lower the risk of various diseases, but more research is needed.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

Isotretinoin is effective for severe acne but requires careful monitoring for side effects, especially in women who could become pregnant.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Thorough history and examination are crucial for diagnosing genetic disorders like juvenile polyposis and hypomelanosis of Ito.

There is a lack of quality online psychological support for alopecia areata patients.

Innovative methods are reducing animal testing and improving biomedical research.

The document argues that the policy suppresses physician freedom of conscience.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Few dermatology programs mention gender-affirming care, highlighting a need for better training and visibility.

Medical associations need to create more resources to improve healthcare for incarcerated individuals.

In vitro methods are crucial for developing effective and humane cosmetic ingredients.

Dermatologists should watch for skin symptoms in COVID-19 patients, prioritize urgent cases, and use telemedicine.

Accurate diagnosis and tailored treatment are crucial for managing common primary care symptoms.

SIG-1451 could be a promising new treatment for atopic dermatitis.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.